Repligen Acquires Engineered Molding Technology

Repligen Corporation agreed to acquire Engineered Molding Technology (EMT), an Albany, New York manufacturer of single-use silicone assemblies, connectors and tubing used in biologic drug manufacturing. The purchase expands Repligen’s single-use ProConnex flow-path capabilities, streamlines its supply chain for ATF, and aims to deliver faster lead-times and a more integrated offering for biopharma and CDMO customers; terms were not disclosed and the deal was expected to close in Q3 2020.